rs1291524243
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000135.4(FANCA):c.856C>T(p.Gln286*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000135.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FANCA | NM_000135.4 | c.856C>T | p.Gln286* | stop_gained | Exon 10 of 43 | ENST00000389301.8 | NP_000126.2 | |
FANCA | NM_001286167.3 | c.856C>T | p.Gln286* | stop_gained | Exon 10 of 43 | NP_001273096.1 | ||
FANCA | NM_001018112.3 | c.856C>T | p.Gln286* | stop_gained | Exon 10 of 11 | NP_001018122.1 | ||
FANCA | NM_001351830.2 | c.760C>T | p.Gln254* | stop_gained | Exon 9 of 10 | NP_001338759.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461798Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 727210
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74334
ClinVar
Submissions by phenotype
Fanconi anemia complementation group A Pathogenic:6
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP5. -
- -
Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. -
- -
- -
- -
not provided Pathogenic:2
FANCA: PVS1, PM2, PM3 -
- -
Fanconi anemia Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln286*) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Fanconi anemia (PMID: 10094191, 12697994). ClinVar contains an entry for this variant (Variation ID: 552738). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
FANCA-related disorder Pathogenic:1
The FANCA c.856C>T variant is predicted to result in premature protein termination (p.Gln286*). This variant was reported in an individual with Fanconi anemia (Wijker et al 1999. PubMed ID: 10094191). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in FANCA are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at